QT Imaging (NASDAQ:QTI) Announces Earnings Results, Misses Estimates By $0.11 EPS

QT Imaging (NASDAQ:QTI) released its earnings results on Wednesday. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.11), Zacks reports. The company had revenue of $6.53 million during the quarter, compared to analysts’ expectations of $6.45 million.

Here are the key takeaways from QT Imaging’s conference call:

• QT Imaging said Q1 2026 revenue rose 133% year over year to $6.5 million, driven by shipment of 13 Breast Acoustic CT systems versus 6 in the prior-year quarter.
• The company highlighted several recent milestones, including FDA 510(k) clearance for an enhancement to improve posterior breast tissue visualization and AMA approval of a new Category 3 CPT code effective January 1, 2027, which it sees as supportive of adoption and future reimbursement.
• QT Imaging also expanded its international footprint with regulatory classification and clearance in the UAE for both its scanner and QTI SaaS Cloud platform, while management said Saudi approval is still pending and expected soon.
• Gross margin for the quarter was 41%, down from 65% a year earlier, as operating expenses increased to $5.0 million and cash and equivalents ended the quarter at $7.0 million.
• Management affirmed full-year 2026 revenue guidance of about $39 million and pointed to contracted scanner orders from distributors, plus early monetization of cloud-based services, as key drivers. The company also extended its senior secured term loan maturity to March 31, 2029, giving it more financial flexibility.

QT Imaging Trading Down 20.1%

NASDAQ QTI traded down $1.35 on Friday, hitting $5.36. 272,139 shares of the stock were exchanged, compared to its average volume of 41,959. QT Imaging has a 52-week low of $0.65 and a 52-week high of $8.50. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.81 and a quick ratio of 2.17. The company has a market capitalization of $64.53 million, a price-to-earnings ratio of -4.32 and a beta of 0.01. The company’s 50-day moving average price is $6.61 and its two-hundred day moving average price is $6.20.

Wall Street Analyst Weigh In

Several research firms have issued reports on QTI. Weiss Ratings began coverage on shares of QT Imaging in a research report on Thursday, January 29th. They issued a “sell (e+)” rating on the stock. Zacks Research raised QT Imaging from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. Finally, Lake Street Capital began coverage on QT Imaging in a research note on Friday, January 30th. They issued a “buy” rating on the stock. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold”.

QT Imaging Company Profile

QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.

QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.